Shanghai Juncell Therapeutics
Clinical trials sponsored by Shanghai Juncell Therapeutics, explained in plain language.
-
Scientists test engineered immune cells to fight tough cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of immune cell therapy called GC203 TIL for people with advanced solid tumors that haven't responded to standard treatments. Doctors will collect immune cells from patients' tumors, genetically modify them in the lab, and then infuse t…
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Scientists test re-engineered immune cells to fight advanced cancers
Disease control Not yet recruitingThis early-stage study tests a new immune cell therapy for people with advanced solid tumors who haven't responded to standard treatments. Researchers collect and modify patients' own tumor-fighting immune cells, then infuse them back after a brief chemotherapy regimen. The study…
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC